Purchases and Sales Made in Q2 2024 in Ab Cellera Biologics Inc. (ABCL)
This table provides information about the institutional ownership of Ab Cellera Biologics Inc. (ABCL) during Q2 2024. The information is specifically focused on institutions that hold shares of AbCellera Biologics Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2024
Q2 2024
|
State Street Corp
Boston, MA |
SELL
|
- |
-132K- 29.25% |
$360K - $623K
|
319K
$901K
|
|
|
Aug 02, 2024
Q2 2024
|
National Bank Of Canada
|
SELL
|
- |
-145K- 78.74% |
$395K - $685K
|
39.1K
$111K
|
|
|
Aug 14, 2024
Q2 2024
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-147K- 93.48% |
$401K - $695K
|
10.2K
$29K
|
|
|
Aug 14, 2024
Q2 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-152K- 87.92% |
$414K - $717K
|
20.8K
$58.9K
|
|
|
Aug 14, 2024
Q2 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-817K- 64.46% |
$2.23M - $3.87M
|
451K
$1.28M
|
|
|
Aug 14, 2024
Q2 2024
|
Lazard Asset Management LLC
New York, NY |
SELL
|
- |
-928K- 45.93% |
$2.53M - $4.39M
|
1.09M
$3.09M
|
|
|
Jul 25, 2024
Q2 2024
|
Baillie Gifford & CO
|
SELL
|
- |
-1.27M- 5.47% |
$3.46M - $6M
|
21.9M
$62M
|
|
|
Aug 13, 2024
Q2 2024
|
Capital World Investors
Los Angeles, CA |
SELL
|
- |
-3.03M- 36.31% |
$8.28M - $14.3M
|
5.32M
$15.1M
|